Similar articles

• Epididymal metastasis from prostatic adenocarcinoma mimicking adenomatoid tumor.

  Rizk CC, Scholes J, Chen SK, Ward J, Romas NA. Rizk CC, et al. Urology. 1990 Dec;36(6):526-30. doi: 10.1016/0090-4295(90)80194-r. Urology. 1990. PMID: 1701066
• Prostate cancer-associated markers.

  Chu TM. Chu TM. Immunol Ser. 1990;53:339-56. Immunol Ser. 1990. PMID: 1713065 Review.
• Uses and limitations of prostate-specific antigen in the laboratory diagnosis of prostate cancer.

  Wells DJ, Bennett BD, Gardner WA. Wells DJ, et al. South Med J. 1988 Feb;81(2):218-20. doi: 10.1097/00007611-198802000-00019. South Med J. 1988. PMID: 2448884
• Re: Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation).

  Fosså JD, Dearnaley DP. Fosså JD, et al. J Urol. 1992 Jan;147(1):173-4. doi: 10.1016/s0022-5347(17)37188-4. J Urol. 1992. PMID: 1370328 No abstract available.
• Prostate-specific antigen testing in untreated and treated prostatic adenocarcinoma.

  Rainwater LM, Morgan WR, Klee GG, Zincke H. Rainwater LM, et al. Mayo Clin Proc. 1990 Aug;65(8):1118-26. doi: 10.1016/s0025-6196(12)62725-6. Mayo Clin Proc. 1990. PMID: 1697014 Review.